Physician profile
Nicholas Rogu
NPI 1922196948
$3,536.28
in general payments reported to CMS, 2019-2025
23 companies · $480 in 2025
The $480 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $299 · 2021: $299 · 2022: $428 · 2023: $305 · 2024: $740 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,525.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $603.39 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $565.21 | 2019-2025 | Bexsero |
| Sanofi-Aventis U.S. LLC | $361.04 | 2024-2025 | |
| Alk-Abello, INC | $318.77 | 2024-2025 | Odactra, Ragwitek, Grastek |
| Ironshore Pharmaceuticals INC. | $275.39 | 2019-2024 | Jornay Pm |
| Cranial Technologies, INC | $222.66 | 2020-2025 | Doc Band |
| Pfizer INC. | $154.98 | 2019-2024 | |
| Corium, LLC | $132.94 | 2022-2024 | Azstarys |
| Seqirus USA INC | $129.65 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $124.18 | 2020 | |
| Supernus Pharmaceuticals, INC. | $108.23 | 2021-2022 | |
| Sanofi Pasteur INC. | $84.12 | 2023-2025 | |
| Cumberland Pharmaceuticals, INC. | $77.94 | 2019-2024 | Kristalose |
| Tris Pharma INC | $62.73 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $44.47 | 2020 | |
| Kyowa Kirin, INC. | $29.93 | 2025 | |
| Hologic Sales and Service, LLC | $21.44 | 2023 | Thinprep 2000 Processor |
| Qiagen, LLC | $21.03 | 2021 | |
| Collegium Pharmaceutical, INC. | $20.13 | 2025 | Jornay Pm |
| Alexion Pharmaceuticals, INC. | $19.17 | 2022 | |
| Sobi, INC | $17.96 | 2019 | |
| Aytu Biopharma, INC. | $15.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Rogu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.